138 related articles for article (PubMed ID: 25664181)
1. Metformin and breast and gynecological cancer risk among women with diabetes.
Soffer D; Shi J; Chung J; Schottinger JE; Wallner LP; Chlebowski RT; Lentz SE; Haque R
BMJ Open Diabetes Res Care; 2015; 3(1):e000049. PubMed ID: 25664181
[TBL] [Abstract][Full Text] [Related]
2. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
3. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
4. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
5. Metformin and the risk of endometrial cancer: a population-based cohort study.
Ko EM; Stürmer T; Hong JL; Castillo WC; Bae-Jump V; Funk MJ
Gynecol Oncol; 2015 Feb; 136(2):341-7. PubMed ID: 25499603
[TBL] [Abstract][Full Text] [Related]
6. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study.
Lin HC; Kachingwe BH; Lin HL; Cheng HW; Uang YS; Wang LH
Pharmacotherapy; 2014 Jan; 34(1):36-45. PubMed ID: 23864581
[TBL] [Abstract][Full Text] [Related]
8. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
[TBL] [Abstract][Full Text] [Related]
9. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
10. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
11. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
[TBL] [Abstract][Full Text] [Related]
12. Metformin and the risk of endometrial cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Gynecol Oncol; 2013 Jun; 129(3):565-9. PubMed ID: 23523618
[TBL] [Abstract][Full Text] [Related]
13. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women.
Redaniel MT; Jeffreys M; May MT; Ben-Shlomo Y; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1785-95. PubMed ID: 22971998
[TBL] [Abstract][Full Text] [Related]
14. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
15. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
16. Use patterns of antidiabetic regimens by patients with type 2 diabetes.
Abdelmoneim AS; Eurich DT; Gamble JM; Simpson SH
Can J Diabetes; 2013 Dec; 37(6):394-400. PubMed ID: 24321720
[TBL] [Abstract][Full Text] [Related]
17. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
[TBL] [Abstract][Full Text] [Related]
18. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
[TBL] [Abstract][Full Text] [Related]
19. Metformin and breast cancer stage at diagnosis: a population-based study.
Lega IC; Fung K; Austin PC; Lipscombe LL
Curr Oncol; 2017 Apr; 24(2):e85-e91. PubMed ID: 28490930
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]